QIAGEN

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

CEO

Thierry L. Bernard

CEOThierry L. Bernard

Employees

5,654

Employees5,654

Headquarters

Venlo, Limburg

HeadquartersVenlo, Limburg

Founded

1996

Founded1996

Employees

5,654

Employees5,654

QGEN Key Statistics

Market cap

7.54B

Market cap7.54B

Price-Earnings ratio

18.90

Price-Earnings ratio18.90

Dividend yield

0.72%

Dividend yield0.72%

Average volume

2.07M

Average volume2.07M

High today

$37.04

High today$37.04

Low today

$36.55

Low today$36.55

Open price

$36.61

Open price$36.61

Volume

3.05M

Volume3.05M

52 Week high

$57.82

52 Week high$57.82

52 Week low

$32.53

52 Week low$32.53

Stock Snapshot

With a market cap of 7.54B, QIAGEN(QGEN) trades at $36.59. The stock has a price-to-earnings ratio of 18.90 and currently yields dividends of 71.9%.

On 2026-05-30, QIAGEN(QGEN) stock moved within a range of $36.55 to $37.04. With shares now at $36.59, the stock is trading +0.1% above its intraday low and -1.2% below the session's peak.

Trading activity shows a volume of 3.05M, compared to an average daily volume of 2.07M.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

QGEN News

Simply Wall St 3h

Qiagen’s New Ebola Assays Test Investor Views On Undervalued Shares

Qiagen launched new digital PCR assays for Bundibugyo ebolavirus surveillance, expanding its infectious disease research tools. The assays are research use onl...

TipRanks 21h

UBS Discloses 2.45% Stake in Qiagen via AFM Notification

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Simply Wall St 4d

Does QuantiFERON Guidance Cut and Shareholder Probe Change The Bull Case For Qiagen?

In May 2026, Qiagen revised its growth guidance for its QuantiFERON tuberculosis testing product, prompting a shareholder rights investigation by Bronstein, Gew...

Analyst ratings

57%

of 21 ratings

Buy

42.9%

Hold

57.1%

Sell

More QGEN News

Simply Wall St 7d

Assessing Qiagen Valuation After New AI Assistant Launch And Expanded NVIDIA Collaboration

Qiagen (NYSE:QGEN) has put AI at the center of its story this month by launching the QIA Agent digital assistant for lab workflows and expanding its AI collabor...

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.